Sofinnova Venture Partners X, L.P. → Aerovate Therapeutics, Inc. JBIO

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 2.26

1,251,725 shares short · -18.4% vs prior

Other 13D/G Filings on Aerovate Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-04-30	SCHEDULE	Atlas Venture Fund XII, L.P.	20.00%	51,406	view →
2025-04-30	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	4.10%	1,324,954	view →
2024-06-20	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2022-07-20	SC	Atlas Venture Fund XII, L.P.	—	—	view →

Other Filings by Sofinnova Venture Partners X, L.P.

Filed	Form	Issuer	Stake	Shares
2024-02-20	SC	Vera Therapeutics, Inc. VERA	—	—	view →
2023-06-21	SC	Karuna Therapeutics, Inc.	—	—	view →
2023-03-01	SC	CinCor Pharma, Inc.	—	—	view →
2022-08-22	SC	CinCor Pharma, Inc.	—	—	view →
2022-02-15	SC	Y-mAbs Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →